What is the purpose of this trial?
The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism in children with all levels of fecal chymotrypsin.
Ages: 3 - 8 years
Dates: 11/01/2015 - 09/30/2017
Last Updated: 10/23/2016
Study HIC#: 1505015948